March 3rd, 2014
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we collaborate with the world for the health of everyone in it. What matters most to us is a healthy outcome for each patient. This calls for the best science, the most creative minds and an openness to collaborate with researchers, governments and patient organizations at every stage – from early discovery to market access and patient education.
Recently our focus on providing innovative therapies and services to transform the lives of patients was recognized by Fortune Magazine, which ranked Johnson & Johnson as the #1 company in the Pharmaceuticals category on its list of the World’s Most Admired Companies. This recognition is a true testament to the people at Janssen who come to work every day with a passion and a commitment to making a difference for patients in need.
Along with our #1 position in Fortune’s Pharmaceuticals category – up from #4 last year – Johnson & Johnson improved or maintained its ranking on all nine attributes of reputation. We now hold the #1 position on People Management, Social Responsibility, Financial Soundness, and Long Term Investment.